Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine

Psychopharmacology

Volumn 131, Issue 4, 1997, Pages 379-387

  Yamamoto, Jyunji ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Animal model; Cocaine; Cortex; EEG power spectra; Hippocampus; Methamphetamine; Phencyclidine; Rabbit; Schizophrenia

Indexed keywords

COCAINE; METHAMPHETAMINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; DRUG ABUSE; DRUG EFFECT; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCHIZOPHRENIA;

ADRENERGIC AGENTS; ANIMALS; CEREBRAL CORTEX; COCAINE; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; HALLUCINOGENS; HIPPOCAMPUS; MALE; METHAMPHETAMINE; PHENCYCLIDINE; RABBITS; SCHIZOPHRENIA;

EID: 0030754562     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050306     Document Type: Article

References (32)

1. Akiyama K, Hamamura T, Ujike H, Kanazaki A, Otsuki S (1990) Mechanism of methamphetamine-induced behavioral sensitization. Clin Neuropharmacol 13 [Suppl. 2]: 587 588
2. Azzaro AJ, Rutledge CO (1973) Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain. Biochem Pharmacol 22: 2801 2813
3. Bleich A, Brown SL, Kahn R, van Praag HM (1988) The role of serotonin in schizophrenia. Schizophr Bull 14:297 315
4. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia implications for schizophrenia and Parkinson's disease. Trends Neurol Sci 13:272 276
5. Deutsch SI, Weizman A, Goldman ME (1988) The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy. Clin Neuropharmacol 11:105 119
6. Dugovic C, Wauquier A, Janssen PAJ (1989) Differential effects of the new antipsychotics risperidon on sleep and wakefulness in the rats. Neuropharmacology 28:1431 1433
7. Ellinwood EH, Lee T (1990) Cocaine-induced psychosis: comparison with amphetamine. Clin Neuropharmacol 13 [Suppl. 2]: 589 590
8. 2 receptors. Psychopharmacology 114:297 308
9. Galloway M (1988) Neurochemical interactions of cocaine with dopaminergic systems. Trends Pharmacol Sci 9:451 454
10. Herrling PL (1990) Mechanism of action of atypical antipsychotics. Clin Neuropharmacol 13 [Suppl. 2]:265-266
11. Itil TM (1978) Effects of psychotropic drugs in qualitatively and quantitatively analyzed human EEG. In: Clark WG, Del Giudice J (eds) Principles of psychopharmacology. Academic Press, New York, pp 261-277
12. Itil TM, Saletu B, Davis S (1972) EEG findings in chronic schizophrenics based on digital computer period analysis and analog power spectra. Biol Psychiatry 5:1-13
13. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301 1308
14. Joyce JN (1983) Multiple dopamine receptors and behavior. Neurosci Biobehav Rev 7:227-256
15. Kane J (1993) Newer antipsychotic drugs. A review of their pharmacology and therapeutics potential. Drugs 46:485 493
16. Longo VG (1978) Effects of psychotropic drugs on EEG of animals. In: Clark WG, Del Giudice J (eds) Principles of psychology. Academic Press, New York, pp 247 260
17. Lows III JA, Seeger TF, Vinick FJ (1988) Atypical antipsychotics recent findings and new perspectives. Med Res Rev 8: 475 497
18. Moller HJ (1994) Negative symptoms in schizophrenia: consideration for clinical trials (working group on negative symptoms in schizophrenia). Psychopharmacology 115:221-228
19. Nabeshima T (1987) Recent topics of phencyclidine, the drug induces psychosis. Yakugaku Zasshi 107:548 569
20. Nishikawa T (1993) Excitatory amino acidergic and schizophrenia. Jpn J Neuropsychopharmacol 15:651 663
21. Pitts DK, Marwash J (1987) Neuropharmacology of cocaine: role of monoaminergic systems. Monogr Neural Sci 13:34 54
22. Popoli P, Reggio R, Pezzola A, Scotti de Carolis A (1995) The stimulation of cholecystokinin receptors in the rostal nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats. Psychopharmacology 120:156-161
23. Raiteri M, Bertollini A, Angelini F, Levi G (1975) d-Amphetamine as a releaser of reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34:189-195
24. Sawyer HW, Everret JW, Green JD (1954) The rabbit diencephalone in stereotaxic coordinates. J Comp Neurol 101:801-824
25. 4 receptors elevated in schizophrenia. Nature 365:441-445
26. 3) as a target for neuroleptics. Nature 347:146-151
27. Steinfels GF, Tam SW, (1989) Selective σ receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol 163:167-170
28. Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 335: 2281-2296
29. Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK-801 is a potent n-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83:7104-7108
30. Yamamoto J (1985) Characteristics of the cortical and hippocampal EEG power spectra of rabbits during normal behavioral states and after administration of CNS acting drugs. Jpn J Pharmacol 37:227-234
31. Yamamoto J (1988) Roles of cholinergic, dopaminergic, noradrenergic, serotonergic and GABAergic systems in changes of the EEG power spectra and behavioral states in rabbits. Jpn J Pharmacol 47:123-134
32. Zukin RS, Zukin SR (1983) A common receptor for phencyclidine and the sigma opiate. In: Kamenka JM, Domino EF, Geneste P (eds) Phencyclidine and related arylcyclohexylamines: present and future applications. NPP Books, Ann Arbor, pp 107-124